化学
恶性肿瘤
癌症研究
荧光
精确肿瘤学
外科切除术
化疗
切除术
癌症
荧光寿命成像显微镜
分子成像
临床实习
肿瘤细胞
循环肿瘤细胞
肿瘤进展
分子探针
癌症影像学
作者
Jiao Lu,Xinyu Song,Xunkai Wang,Chuanhao Xu,Yonghai Wang,Yanlong Xing,Fabiao Yu,Kun Dou
出处
期刊:Analytical Chemistry
[American Chemical Society]
日期:2025-11-25
卷期号:97 (48): 26948-26959
被引量:12
标识
DOI:10.1021/acs.analchem.5c06362
摘要
Despite advancements in multimodal cancer therapies, complete surgical resection remains the cornerstone of curative treatment for solid tumors. However, the inability to precisely visualize tumor margins intraoperatively and monitor therapeutic responses in real-time poses significant clinical challenges. Through rational molecular engineering strategy, we propose a novel class of tandem-locked, dual-activatable NIR-II fluorescent probes (HY-1-NO 2 to HY-4-NO 2 ) engineered for simultaneous response to NTR and microenvironmental viscosity, two biomarkers strongly associated with tumor malignancy and treatment response. Among all of the designed probes, HY-2-NO 2 demonstrates robust NIR-II emission at 910 nm with a 20-fold enhancement in fluorescence upon activation. This dual-key mechanism ensures high specificity and minimal background, enabling accurate intraoperative delineation of tumor margins with precision down to 0.2 mm. Furthermore, HY-2-NO 2 facilitates real-time evaluation of the paclitaxel-induced therapeutic response, with fluorescence intensity positively correlating with tumor suppression. The probe also successfully distinguishes tumor from normal tissues in clinical specimens, demonstrating strong translational potential. Thus, this study provides an integrated theranostic platform that combines real-time surgical navigation with functional monitoring of treatment efficacy, addressing critical gaps in precision oncology.
科研通智能强力驱动
Strongly Powered by AbleSci AI